Your browser doesn't support javascript.
loading
Novel chimeric TLR2/NOD2 agonist CL429 exhibited significant radioprotective effects in mice.
Cheng, Ying; Du, Jicong; Liu, Ruling; Dong, Suhe; Cai, Jianming; Gao, Fu; Liu, Cong.
Afiliação
  • Cheng Y; Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.
  • Du J; Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.
  • Liu R; Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.
  • Dong S; Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.
  • Cai J; Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.
  • Gao F; Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.
  • Liu C; Department of Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.
J Cell Mol Med ; 25(8): 3785-3792, 2021 04.
Article em En | MEDLINE | ID: mdl-33609010

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protetores contra Radiação / Acetilmuramil-Alanil-Isoglutamina / Irradiação Corporal Total / Receptor 2 Toll-Like / Proteína Adaptadora de Sinalização NOD2 / Síndrome Aguda da Radiação / Sistema Hematopoético / Intestinos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protetores contra Radiação / Acetilmuramil-Alanil-Isoglutamina / Irradiação Corporal Total / Receptor 2 Toll-Like / Proteína Adaptadora de Sinalização NOD2 / Síndrome Aguda da Radiação / Sistema Hematopoético / Intestinos Idioma: En Ano de publicação: 2021 Tipo de documento: Article